Sanjay Nayak, Chief Strategy Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 1,897 shares at $10.78 ($20K) on 2026-08-24, disclosed to the SEC on 2026-08-26.
Open-market sale of $20k OCUL by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-02-17 | $94K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $23K | — | Filing → |
| OCUL | SELL | 2025-08-27 | $23K | — | Filing → |